Induced pluripotent stem cells (iPSCs) are pluripotent stem cells generated from adult cells by reprogramming. iPSCs have the same properties as embryonic stem cells, and therefore self-renew and ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Scientists have identified a previously unknown type of neural stem cell (pNSC) that exists outside the brain and spinal cord ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

The treatment begins with "reprogrammed" stem cells, known formally as induced pluripotent stem cells, or iPSCs. These are adult somatic (non-reproductive) cells that have been introduced to ...

Human induced Pluripotent Stem Cells (hiPSCs), these are cells extracted from a patient's skin or blood and are reprogrammed by researches to replicate as stem cells. Researchers can now examine ...

Researchers at Keio University have begun using induced pluripotent stem cells (iPS) to treat and maybe even cure severe spinal cord injuries. The iPS technology was first conceived by Shinya ...

Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.